TR200000135T2 - Tiazolidinedion ve sülfonilüre ile diabet tedavisi. - Google Patents

Tiazolidinedion ve sülfonilüre ile diabet tedavisi.

Info

Publication number
TR200000135T2
TR200000135T2 TR2000/00135T TR200000135T TR200000135T2 TR 200000135 T2 TR200000135 T2 TR 200000135T2 TR 2000/00135 T TR2000/00135 T TR 2000/00135T TR 200000135 T TR200000135 T TR 200000135T TR 200000135 T2 TR200000135 T2 TR 200000135T2
Authority
TR
Turkey
Prior art keywords
thiazolidinedione
sulfonylurea
diabetes treatment
mammal
mellitus
Prior art date
Application number
TR2000/00135T
Other languages
English (en)
Turkish (tr)
Inventor
Edwin Buckingham Robin
Alistair Smith Stephen
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200000135(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200000135T2 publication Critical patent/TR200000135T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2000/00135T 1997-07-18 1998-07-16 Tiazolidinedion ve sülfonilüre ile diabet tedavisi. TR200000135T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
TR200000135T2 true TR200000135T2 (tr) 2000-05-22

Family

ID=10816177

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00135T TR200000135T2 (tr) 1997-07-18 1998-07-16 Tiazolidinedion ve sülfonilüre ile diabet tedavisi.

Country Status (40)

Country Link
EP (1) EP0998291B2 (https=)
JP (2) JP2001510158A (https=)
KR (1) KR100680667B1 (https=)
CN (1) CN1264302A (https=)
AP (1) AP1318A (https=)
AR (2) AR016768A1 (https=)
AT (1) ATE366577T1 (https=)
AU (1) AU743269B2 (https=)
BG (1) BG64892B1 (https=)
BR (1) BR9810904A (https=)
CA (1) CA2297115C (https=)
CO (1) CO4940422A1 (https=)
CY (1) CY1107745T1 (https=)
CZ (1) CZ302668B6 (https=)
DE (1) DE69838066T3 (https=)
DK (1) DK0998291T4 (https=)
DZ (1) DZ2564A1 (https=)
EA (1) EA003303B1 (https=)
ES (1) ES2290989T5 (https=)
GB (1) GB9715306D0 (https=)
HU (1) HU229119B1 (https=)
ID (1) ID24198A (https=)
IL (1) IL134045A0 (https=)
IN (1) IN189035B (https=)
MA (1) MA26522A1 (https=)
MY (1) MY138246A (https=)
NO (1) NO326356B1 (https=)
NZ (3) NZ520652A (https=)
OA (1) OA11632A (https=)
PE (1) PE99799A1 (https=)
PL (2) PL199125B1 (https=)
PT (1) PT998291E (https=)
SI (1) SI0998291T2 (https=)
SK (2) SK288053B6 (https=)
TR (1) TR200000135T2 (https=)
TW (1) TW586926B (https=)
UA (1) UA70302C2 (https=)
UY (1) UY25103A1 (https=)
WO (1) WO1999003476A1 (https=)
ZA (1) ZA986365B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
EP1897547A1 (en) * 1999-07-13 2008-03-12 Medicure Inc. Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
EP1832291A3 (en) * 1999-07-13 2009-11-04 Medicure Inc. use of pyridoxal phosphate for the treatment of diabetes and related complications
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
ATE508738T1 (de) 2001-01-12 2011-05-15 Sun Pharma Advanced Res Co Ltd System zur beabstandeten abgabe von arzneimitteln
MXPA06004639A (es) * 2003-10-31 2006-06-27 Takeda Pharmaceutical Preparacion solida que comprende sensibilizador de insulina, secretagogo de insulina y ester de acidos grasos de polioxietileno sorbitano.
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法
ZA200805147B (en) 2005-12-22 2010-05-26 Takeda Pharmaceutical Solid preparation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
EP0528764B1 (en) * 1991-08-16 1996-06-12 Sandoz Ltd. Inhaler for administration of powdery substances
US5900435A (en) * 1991-08-26 1999-05-04 Pharmacia & Upjohn Company Composition, food product and uses of 3-guanidinopropionic acid
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
BG104139A (en) 2000-11-30
JP2005247865A (ja) 2005-09-15
EP0998291A1 (en) 2000-05-10
NZ520652A (en) 2004-06-25
NO20000229D0 (no) 2000-01-17
UY25103A1 (es) 2000-12-29
KR20010021948A (ko) 2001-03-15
TW586926B (en) 2004-05-11
DE69838066D1 (de) 2007-08-23
CO4940422A1 (es) 2000-07-24
EP0998291B1 (en) 2007-07-11
IL134045A0 (en) 2001-04-30
ATE366577T1 (de) 2007-08-15
PT998291E (pt) 2007-10-11
AP2000001734A0 (en) 2000-03-31
NO20000229L (no) 2000-01-17
EA200000141A1 (ru) 2000-08-28
CA2297115A1 (en) 1999-01-28
HU229119B1 (en) 2013-08-28
JP2001510158A (ja) 2001-07-31
NO326356B1 (no) 2008-11-17
PL199125B1 (pl) 2008-08-29
HK1029272A1 (en) 2001-03-30
SK602000A3 (en) 2000-07-11
PL338127A1 (en) 2000-09-25
KR100680667B1 (ko) 2007-02-09
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
ES2290989T5 (es) 2011-11-11
HUP0003634A2 (hu) 2001-07-30
SI0998291T2 (sl) 2011-10-28
GB9715306D0 (en) 1997-09-24
SK288053B6 (sk) 2013-03-01
AU8448798A (en) 1999-02-10
NZ501256A (en) 2002-09-27
SK287823B6 (sk) 2011-11-04
BG64892B1 (bg) 2006-08-31
DZ2564A1 (fr) 2003-02-15
AP1318A (en) 2004-10-22
CN1264302A (zh) 2000-08-23
EP0998291B2 (en) 2011-07-06
HUP0003634A3 (en) 2003-04-28
AU743269B2 (en) 2002-01-24
AR016768A1 (es) 2001-08-01
DK0998291T4 (da) 2011-09-26
WO1999003476A1 (en) 1999-01-28
BR9810904A (pt) 2000-09-26
CZ302668B6 (cs) 2011-08-24
SI0998291T1 (sl) 2007-12-31
NZ515555A (en) 2002-09-27
CZ2000173A3 (en) 2001-05-16
AR019331A2 (es) 2002-02-13
CY1107745T1 (el) 2013-04-18
ES2290989T3 (es) 2008-02-16
IN189035B (https=) 2002-12-07
UA70302C2 (uk) 2004-10-15
DK0998291T3 (da) 2007-11-05
MA26522A1 (fr) 2004-12-20
MY138246A (en) 2009-05-29
DE69838066T3 (de) 2012-03-29
PE99799A1 (es) 1999-12-22
CA2297115C (en) 2010-02-23
OA11632A (en) 2004-11-22
ID24198A (id) 2000-07-13
ZA986365B (en) 2000-01-17

Similar Documents

Publication Publication Date Title
TR200000134T2 (tr) Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi.
TR199903057T2 (xx) Diabetin tiazolidinedion ve metformin ile tedavisi.
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
TR200100600T2 (tr) İnsülinotropik peptitlerin kullanımı.
NO940436L (no) Forlenget avgivelse av peptider
TR200100079T2 (tr) Glikoza karşı ß-hücre tepkisini arttıran glukagon benzeri peptid-1
DE69327309D1 (de) Verwendung eines peptids
YU37301A (sh) Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
ATE193541T1 (de) Insulinotropes hormon
BR9106977A (pt) Metodo para suprimir destruicao autoimune de celuias beta pancreaticas,formulacao farmaceutica,metodo de profilaxia,metodo para prevenir o surgimento de diabetes tipo 1 e metodo para tratar um mamifero
TR200101174T2 (tr) Migren tedavisi için 5HT1, reseptör agonistleri ve metoklopramid.
DK1294757T3 (da) Glucagonlignende peptid 1-analoger
TR200000135T2 (tr) Tiazolidinedion ve sülfonilüre ile diabet tedavisi.
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
BR9810444A (pt) Tratamento de diabete com rosiglitazona e insulina
TR200000133T2 (tr) Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi.
TR199903096T2 (xx) Diabetin tiazolidinedion ve s�lfonil�re ile tedavisi.
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
BR9810186A (pt) Tratamento de diabete com tiazolidinadiona e inibidor de alfa-glicosidade
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
EP1173186A4 (en) USE OF TAGATOSIS TO INCREASE KEY BLOOD FACTORS
TR200000958T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı.
IL143088A0 (en) A method for the treatment of type 2 diabetes mellitus and conditions associated therewith, and a pharmaceutical composition comprising an insulin sensitiser for use in such a method
ECSP982593A (es) Nuevo metodo de tratamiento vi
ECSP982542A (es) Nuevo metodo de tratamiento iii